Have your own idea? Try our Stock Screener
Pakistani (KSE) Pharma Industry Analysis
UpdatedMay 21, 2026
DataAggregated Company Financials
Companies11
- 7D-2.6%
- 3M-15.5%
- 1Y-4.6%
- YTD-18.0%
Over the last 7 days, the Pharma industry has dropped 2.6%, driven by declines in GlaxoSmithKline Pakistan and Abbott Laboratories (Pakistan) of 3.7% and 4.1%, respectively. However, the industry is down 4.6% over the past year. Looking forward, earnings are forecast to grow by 11% annually.
Industry Valuation and Performance
Has the Pakistani Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 21 May 2026 | PK₨430.9b | PK₨316.6b | PK₨34.3b | 13x | 12.6x | 1.4x |
| Sat, 18 Apr 2026 | PK₨488.9b | PK₨311.0b | PK₨32.8b | 14.9x | 14.9x | 1.6x |
| Mon, 16 Mar 2026 | PK₨426.2b | PK₨304.4b | PK₨30.1b | 13.9x | 14.2x | 1.4x |
| Wed, 11 Feb 2026 | PK₨549.5b | PK₨297.3b | PK₨29.2b | 18x | 18.8x | 1.8x |
| Fri, 09 Jan 2026 | PK₨567.6b | PK₨297.3b | PK₨29.2b | 17.6x | 19.4x | 1.9x |
| Sun, 07 Dec 2025 | PK₨500.0b | PK₨297.4b | PK₨29.4b | 15.6x | 17x | 1.7x |
| Tue, 04 Nov 2025 | PK₨518.9b | PK₨297.4b | PK₨30.1b | 16.5x | 17.3x | 1.7x |
| Thu, 02 Oct 2025 | PK₨546.3b | PK₨287.3b | PK₨29.1b | 22.4x | 18.8x | 1.9x |
| Sat, 30 Aug 2025 | PK₨514.4b | PK₨285.5b | PK₨28.8b | 24.1x | 17.8x | 1.8x |
| Mon, 28 Jul 2025 | PK₨478.9b | PK₨279.5b | PK₨26.2b | 22.4x | 18.3x | 1.7x |
| Wed, 25 Jun 2025 | PK₨449.7b | PK₨279.5b | PK₨26.2b | 21.7x | 17.1x | 1.6x |
| Fri, 23 May 2025 | PK₨452.5b | PK₨279.5b | PK₨26.2b | 18.7x | 17.3x | 1.6x |
| Sun, 20 Apr 2025 | PK₨487.1b | PK₨272.6b | PK₨23.2b | 21.4x | 21x | 1.8x |
| Tue, 18 Mar 2025 | PK₨473.4b | PK₨266.0b | PK₨20.9b | 26x | 22.7x | 1.8x |
| Thu, 13 Feb 2025 | PK₨495.8b | PK₨257.1b | PK₨19.2b | 25.5x | 25.9x | 1.9x |
| Sat, 11 Jan 2025 | PK₨448.1b | PK₨257.1b | PK₨19.2b | 22.3x | 23.4x | 1.7x |
| Mon, 09 Dec 2024 | PK₨460.9b | PK₨257.0b | PK₨19.0b | 22.4x | 24.2x | 1.8x |
| Wed, 06 Nov 2024 | PK₨356.7b | PK₨256.6b | PK₨19.2b | 19.5x | 18.6x | 1.4x |
| Fri, 04 Oct 2024 | PK₨278.2b | PK₨251.2b | PK₨12.3b | 17.3x | 22.6x | 1.1x |
| Sun, 01 Sep 2024 | PK₨258.5b | PK₨252.2b | PK₨12.2b | 16.4x | 21.2x | 1x |
| Tue, 30 Jul 2024 | PK₨245.3b | PK₨243.6b | PK₨8.3b | 17.1x | 29.7x | 1x |
| Thu, 27 Jun 2024 | PK₨239.5b | PK₨243.6b | PK₨8.3b | 15.9x | 29x | 1x |
| Sat, 25 May 2024 | PK₨225.3b | PK₨237.0b | PK₨7.6b | 21.1x | 29.5x | 1x |
| Mon, 22 Apr 2024 | PK₨186.8b | PK₨228.8b | PK₨6.6b | 37.4x | 28.4x | 0.8x |
| Wed, 20 Mar 2024 | PK₨167.5b | PK₨224.1b | PK₨6.3b | 21x | 26.5x | 0.7x |
| Fri, 16 Feb 2024 | PK₨159.1b | PK₨221.2b | PK₨6.3b | 19.5x | 25.3x | 0.7x |
| Sun, 14 Jan 2024 | PK₨168.1b | PK₨221.2b | PK₨6.3b | 20.5x | 26.7x | 0.8x |
| Tue, 12 Dec 2023 | PK₨178.1b | PK₨219.4b | PK₨6.2b | 23x | 28.9x | 0.8x |
| Thu, 09 Nov 2023 | PK₨147.9b | PK₨218.2b | PK₨6.2b | 19.8x | 23.9x | 0.7x |
| Sat, 07 Oct 2023 | PK₨125.6b | PK₨209.6b | PK₨6.5b | 16x | 19.4x | 0.6x |
| Mon, 04 Sep 2023 | PK₨123.4b | PK₨209.2b | PK₨8.4b | 12.1x | 14.8x | 0.6x |
| Wed, 02 Aug 2023 | PK₨141.5b | PK₨205.6b | PK₨8.7b | 13x | 16.2x | 0.7x |
| Fri, 30 Jun 2023 | PK₨127.2b | PK₨205.6b | PK₨8.7b | 12.2x | 14.6x | 0.6x |
| Sun, 28 May 2023 | PK₨134.8b | PK₨203.2b | PK₨11.1b | 13.1x | 12.2x | 0.7x |
Price to Earnings Ratio
12.2x
Current Industry PE
- Investors are pessimistic on the Pakistani Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 12.6x which is lower than its 3-year average PE of 21.0x.
- The industry is trading close to its 3-year average PS ratio of 1.3x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 46% per year over the last three years.
- Revenues for these companies have grown 16% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Pakistani Healthcare industry?
| PK Market | -1.64% | |
| Healthcare | -2.63% | |
| Pharma | -2.57% | |
| Pharma | -2.57% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| AGP AGP | PK₨186.24 | 4.4% +PK₨2.2b | -0.1% | PE13.9x | |
| SEARL Searle | PK₨89.03 | 1.5% +PK₨764.7m | 19.3% | PE24.3x | |
| BFBIO BF Biosciences | PK₨134.98 | 1.6% +PK₨193.5m | -27.0% | PE20.1x | |
| FEROZ Ferozsons Laboratories | PK₨372.17 | 0.8% +PK₨127.8m | 14.7% | PE17.2x | |
| HPL Hoechst Pakistan | PK₨4.01k | 0.1% +PK₨53.0m | 25.8% | PE12.6x |